How to Buy Champions Oncology Stock

Champions Oncology Inc

Champions Oncology, Inc. develops and sells technology solutions and products to personalize the development and use of oncology drugs in the United States.

Champions Oncology stock last closed at $6.83, up 5.73% from the previous day, and has increased 53.14% in one year. It has overperformed other stocks in the Biotechnology industry by 1.02 percentage points. Champions Oncology stock is currently +82.13% from its 52-week low of $3.75, and -43.04% from its 52-week high of $11.99.

As of Sep 12, 2025, there are 13.78M shares of CSBR outstanding. The market cap of CSBR is $94.10M. In the last 24 hours, 23,600 CSBR shares were traded.

How to Buy Champions Oncology Stock

Wondering how to invest in Champions Oncology stock? Here's how.

  1. Choose where to buy Champions Oncology stock: You need to choose a stock brokerage, but don't worry - we've sifted through dozens of online stock brokerages and apps to help you determine where to buy Champions Oncology stock.
  2. Open a brokerage account: Sign up for 0% commission trading with the highest-rated brokerage we've identified.
  3. Deposit funds into your brokerage account: Choose your payment method and add your information.
  4. Research Champions Oncology stock: The Champions Oncology ticker symbol is CSBR. Is Champions Oncology stock a good investment? Should you buy shares of CSBR? How do CSBR's underlying business fundamentals look? Do top analysts think Champions Oncology is a good buy? Why has CSBR's stock price moved recently? (Hint: Our stock research website can help you understand if CSBR is a good stock to buy).
  5. Execute your CSBR trade: Decide if you will purchase CSBR shares at the current market price or use a limit order to purchase CSBR shares at a specific price.
  6. Get updates on your investment in CSBR: Create a watchlist to monitor your new investment in Champions Oncology shares.

Step 1: Choose where to buy Champions Oncology stock

You will need a brokerage account in order to access the NASDAQ market and buy CSBR shares.

A brokerage account is an investment account that enables you to buy and sell a number of financial instruments, such as stocks, bonds, mutual funds, and ETFs.

Our preferred brokerage: eToro

We believe that eToro is the best brokerage. Here's why:

  • You can invest in stocks with 0% commissions: Invest without commissions.
  • Buy fractional shares: Even if you don't have the money to buy a full share, you can still invest in the stock.
  • Access to global financial markets: From Technology to Healthcare, New York to Tokyo (for US users, only US stocks are available) — you can fill your portfolio with stocks from the globe's leading exchanges.
  • Social investing: eToro boasts a community of more than 20 million users worldwide. Talk to, learn from, and copy the crypto trades of other investors.
  • Security: eToro is a regulated and licensed fintech leader.
  • Buy other assets: Such as ETFs and cryptos.

Get $10 towards your purchase of shares by opening an account with eToro now. This offer is only for US users.

Open eToro Account
eToro securities trading is offered by eToro USA Securities, Inc. (“the BD”), member of FINRA and SIPC. Cryptocurrency is offered by eToro USA LLC (“the MSB”) (NMLS: 1769299) and is not FDIC or SIPC insured. Investing involves risk, and content is provided for educational purposes only, does not imply a recommendation, and is not a guarantee of future performance. https://www.wallstreetzen.com is not an affiliate and may be compensated if you access certain products or services offered by the MSB and/or the BD.

Step 2: Open a brokerage account

Now that you've chosen the right brokerage, you'll need to fill out some personal information so you are able to invest in CSBR today.

How to Create a New Investment Account on eToro

  1. Click here to get started.
    eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
  2. Enter your personal data to create your new trading account.
  1. Send your data by clicking the "Create Account" button.
  2. Get started with eToro today
    eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.

Step 3: Deposit funds into your brokerage account

Now that you have filled out your info on the best stock market app for beginners, you can securely and quickly fund your account:

Watch the walkthrough below if you need help transferring money into your new brokerage account.

Get started with eToro today
eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.

Step 4: Research Champions Oncology stock

Once you have figured out the best place to buy Champions Oncology stock, it's important to evaluate their stock before you buy, so you can comprehend the risk and upside.

Champions Oncology shares data

CSBR Price
$6.83
1w %
-0.15%
1y %
53.14%
5y %
-9.89%
P/E
20.09x
P/B
24.95x
P/S
1.64x
PEG
0.33x
Revenue
$56.94M
Earnings
$4.70M
Fore. Rev. Growth
N/A
Fore. Earn. Growth
N/A
Market Cap
$94.10M
Next Earnings
N/A
Next Dividend
N/A

Champions Oncology Due Diligence Checks

WallStreetZen was designed to help average investors do more accurate fundamental analysis in minutes instead of hours.

You can see all of the due diligence checks on CSBR's stock page.

Is CSBR stock overvalued?

Analysts use a variety of different financial metrics, analyses, models, and charts to gauge CSBR's true value.

Using relative valuations metrics:

  • CSBR could be undervalued based on its P/E ratio of 20.09x, relative to Biotechnology industry P/E ratio of -97.08x
  • CSBR could be overvalued based on its P/B ratio of 24.95x, relative to Biotechnology industry P/B ratio of 4.65x
  • CSBR may be undervalued based on its PEG ratio of 0.33x

You can do more valuation analysis on CSBR's stock here.

CSBR Financials at a glance

Signs that CSBR is financially healthy:

  • CSBR profit margin has gone up from -14.5% to 8.3% in the past year.
  • There are more short-term assets than long-term liabilities on the CSBR balance sheet.
  • CSBR's operating cash flow of $7.39M allows it to safely service it's debt of $6.11M.
  • CSBR earnings of $4.63M is not sufficient to cover its interest payments.

Signs that CSBR is not financially healthy:

  • CSBR has a relatively high debt to equity ratio of 7.58.
  • Total CSBR debt is higher than 5 years ago, relative to shareholder equity.
  • There are more short-term liabilities than short-term assets on the CSBR balance sheet.

CSBR Trading Indicators

SMA10
6.77
SMA20
6.91
SMA50
7.11
SMA100
6.95
SMA200
7.86
MACD
-0.09
MACD Signal
-0.06
MACD Histogram
-0.02
RSI
49.84
Stochastic %K
21
Stochastic %D
10.32
StochRSI %K
27.63
StochRSI %D
11.54

CSBR Performance Numbers

Last year, CSBR earnings were $4.70M. During the last 4 year, CSBR's earnings have increased by 83.48% per year. This was faster than the Biotechnology industry average of 8.77%.

Last year, CSBR revenue was $56.94M. Over the past 5 year, CSBR's revenue has gone up by 12.13% per year. This was slower than the Biotechnology industry average of 66.52%.

Learn more about CSBR's earnings and revenue performance here.

Are CSBR insiders buying or selling the stock?

In the last year, insiders at CSBR have bought more shares than they have sold.

Joel Ackerman, Director of CSBR, was the latest CSBR insider to buy. They bought $90,501.81 worth of CSBR stock on Oct 31, 2024.

Dig into more about who owns CSBR stock here.

Can I get consistent income from CSBR stock?

No, Champions Oncology doesn't provide an income stream by paying out dividends.

Get opinions from other investors

One of the reasons eToro is our top-rated brokerage is because of its social trading community.

Click below to learn what other investors have to say.

Step 5: Execute your CSBR trade

There are two primary options:

  • Market order: A market order is an order to buy or sell a security at the best price on the market.
    Market orders are generally fine for most investors.
  • Limit order: A limit order allows you to buy or sell a security at a specific price (or better).
    If you want to be sure you're buying or selling at an exact dollar amount, place a limit order.

Press the Open button and eToro will place the order.

If you need additional help with investing in stocks on eToro, click the helpful video below:

Open eToro Account

Step 6: Get updates on your investment in CSBR

Now that you own some shares in CSBR, you'll want to keep up with your new investment.

Start a watchlist to track your CSBR stock.

CSBR Feed

How to Buy Stock in Champions Oncology

To reiterate, here are the 6 steps you need to take to buy Champions Oncology stock right now:

  1. Choose where to buy Champions Oncology stock
  2. Open a brokerage account
  3. Deposit funds into your brokerage account
  4. Research Champions Oncology stock
  5. Execute your CSBR trade
  6. Get updates on your investment in CSBR

If you require a place to buy stocks, eToro is our recommended venue.

Get Started with eToro Today
eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.

If you would like to keep tabs on your new investment in Champions Oncology, create your watchlist below.

NASDAQ: CSBR
$6.83+0.37 (+5.73%)
Updated Sep 12, 2025
Open eToro Account
Your capital is at risk.
NASDAQ: CSBR
$6.83+0.37 (+5.73%)
Updated Sep 12, 2025
Open eToro Account
Your capital is at risk.

FAQ

How much does it cost to buy one Champions Oncology share?

As of Sep 12, 2025, it costs $6.83 to buy one share of Champions Oncology stock.

Remember, eToro's fractional share buying allows you to buy partial shares of stocks and ETFs. Even if you only have $3, you can buy 0.439 shares of CSBR.

Get Started with eToro Today
eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.

What is the best way to buy Champions Oncology stock?

One way to place an order for Champions Oncology stock is with a brokerage account.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.